The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

South Africa plans to 'share' 1 mln AstraZeneca doses via African Union

Tue, 16th Feb 2021 08:57

JOHANNESBURG, Feb 16 (Reuters) - South Africa plans to
"share" the 1 million AstraZeneca COVID-19 vaccine doses
it received from the Serum Institute of India with other African
countries via the African Union, a senior health official said
on Tuesday.

Anban Pillay, deputy director-general at the Department of
Health, told Reuters it was not true that South Africa had asked
the Serum Institute to take the 1 million doses back, as
reported by Indian daily The Economic Times.

Pillay added that South Africa planned to recover the money
spent on the AstraZeneca doses, which arrived in the country at
the start of the month, but was still finalising how to do that.

(Reporting by Alexander Winning
Editing by Tim Cocks)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.